Ongoing advancements of coronary computed tomographic angiography (CTA) continue to challenge the role of invasive coronary angiography (ICA) as the gold standard for the evaluation of coronary artery disease (CAD). We sought to investigate the diagnostic accuracy of 320-slice CTA for detecting obstructive CAD in reference to ICA and nuclear myocardial perfusion imaging using single-photon emission computed tomography.
Song et al; CT and Invasive Coronary Angiography for CAD C ardiovascular disease is the leading cause of morbidity and mortality in the United States and worldwide. 1 Early detection and timely treatment of coronary artery disease (CAD) is critical and may significantly reduce morbidity and mortality. Invasive coronary angiography (ICA) is associated with considerable cost and procedure-related risks, but it still remains the standard for the diagnosis of obstructive CAD. Computed tomographic angiography (CTA) has emerged as a promising, noninvasive anatomic imaging modality for coronary artery evaluation. Since the introduction of 64-detector row CTA, many studies comparing the diagnostic performance of CTA to ICA as the reference standard have reported excellent accuracy for detecting obstructive CAD, with per-patient sensitivity and negative predictive values ranging from 91% to 99% and 83% to 99%, respectively. 2 Interestingly, however, agreement between computed tomography (CT) and ICA decreases considerably on a per-vessel and, particularly, on a per-segment-level analysis. 3, 4 These discrepancies may not be apparent in a per-patient-level evaluation because only the highest degree stenosis is typically considered for comparison. For example, a CT scan detecting only 1 stenosis of 50% in a patient will be computed as true positive (=agreement) in studies, despite ICA reporting 5 stenoses of 90%. In clinical practice, such differences undermine clinicians' acceptance of CTA as a valid alternative to ICA. Potential reasons for disagreement among CT and ICA include their respective limitations as imaging tools and reader variability. 5 More recently, 320-detector row CTA has become available. 6 It enables imaging the entire coronary tree in a single gantry rotation within a single heartbeat, resulting in improved contrast homogeneity and a decrease of misregistration artifacts. By facilitating prospective scan triggering, 320-row CTA also leads to reduced radiation doses and intravenous contrast requirements while maintaining the diagnostic accuracy as reported in early generation scanners. 6 However, no rigorous investigation, involving multicenter data acquisition and core laboratory analysis, has tested the diagnostic accuracy of 320-slice CT. We set forth to assess CTA diagnostic performance versus both anatomic and functional standards.
METHODS
Requests for access to materials and methods used for this investigation may be sent to the corresponding author. Permission from the study sponsor will be required for data sharing.
Study Design
The CORE320 (Coronary Artery Evaluation Using 320-Row Multidetector Computed Tomography Angiography and Myocardial Perfusion) is a prospective, multicenter diagnostic study performed at 16 hospitals in 8 countries (https:// www.clinicaltrials.gov; NCT00934037). 7 All centers received study approval from their local institutional review boards, and all patients provided written informed consent to participate. The study was designed by the CORE320 Steering Committee; the sponsors had no role in study design, data accrual, data analysis, or manuscript preparation.
Population of Patients
The CORE320 study design and results of the primary endpoints have been published. 7, 8 Eligible patients were between 45 and 85 years of age, had suspected or known CAD, and were referred for conventional ICA. Patients were excluded if they had history of known allergy to iodinated contrast media, elevated serum creatinine (>1.5 mg/dL), or calculated creatinine clearance of <60 mL/min, atrial fibrillation, second-or third-degree atrioventricular block, previous cardiac surgery, coronary intervention within the past 6 months, evidence of acute coronary syndrome with thrombolysis, myocardial infarction risk score ≥5, or elevated cardiac enzymes in the past 72 hours, high radiation exposure (≥5.0 rems) in the 18 months before consent, and body mass index >40 m/kg 2 
CLINICAL PERSPECTIVE
We tested the agreement of 320-slice coronary computed tomographic (CT) angiography against conventional invasive angiography in 381 patients who underwent both tests in the prospective CORE320 international study (Coronary Artery Evaluation Using 320-Row Multidetector Computed Tomography Angiography and Myocardial Perfusion). We found an ≈90% accuracy of CT for identifying patients with at least 1 significant coronary arterial stenosis, defined as ≥50% by quantitative coronary angiography. However, the accuracy decreased to 81% when comparing individual coronary arterial segments for agreement. Severe coronary calcification remains an obstacle for CT to accurately assess the coronary arterial anatomy. On the contrary, both CT and invasive angiography had similar accuracy for identifying patients with inducible myocardial ischemia detected by nuclear perfusion imaging. Both modalities also similarly performed for predicting clinically driven coronary artery revascularization. CT scanning was associated with less radiation exposure to patients compared with invasive coronary angiography. Our results suggest CT may be a valid alternative to cardiac catheterization for establishing the diagnosis of coronary artery disease. However, a change in clinical practice patterns likely requires evidence from clinical studies demonstrating equivalence of CT to invasive angiography for guiding medical management. among others. Women of childbearing potential had a negative pregnancy test within 24 hours before undergoing CTA. All subjects underwent coronary CTA within 60 days of the ICA. Investigators, physicians, and patients were unaware of the results of coronary CTA. The study enrolled and analyzed all patients regardless of calcium score and presence of stents. All patients also underwent clinical or research-driven myocardial perfusion imaging using single-photon emission computed tomography (SPECT-MPI). Of 436 eligible patients, 381 completed all imaging and represent the study population.
Acquisition and Analysis of Data From CTA
The methods used for CTA have been described in detail. 7, 9, 10 In brief, 2 CT images (coronary calcium scoring and angiography) were acquired before conventional coronary angiography using a single protocol developed for 320-row scanners with a slice thickness of 0.5 mm (Aquilion ONE; Canon [formerly Toshiba] Medical Systems, Otawara, Japan). Patient preparation included oral (75-150 mg) or IV (≤15 mg) metoprolol and sublingual, fast acting nitrates. CTA acquisition was performed with 50 to 70 mL of iodinated contrast (iopamidol, 370 mg iodine per mL) injected intravenously at 4.0 to 5.0 mL/s for each of the separate, axial, prospectively ECG-triggered acquisitions.
Deidentified sinograms for all CTA acquisitions were reconstructed, processed, and interpreted by independent core laboratories. Each CTA study was interpreted by 2 level III certified and independent investigators, and disagreements were resolved by consensus. All coronary artery segments of ≥1.0 mm in diameter were examined for the presence of CADs using a 19-segment coronary artery model. All coronary lesions with a subjective stenosis of ≥30% underwent quantitative evaluation using a Vitrea fX, version 3.0, workstation (Vital Images, Minnetonka, MN).
Data Acquisition and Analysis of Data From ICA
Conventional coronary angiography was performed within 60 days of multidetector CTA using standard techniques. Quantitative coronary angiography (QCA) was performed using standard, validated analysis software (CAAS II QCA Research; version 2.0.1, PIE Medical Imaging, Maastricht, the Netherlands), and all coronary segments ≥1.5 mm in diameter were analyzed quantitatively using a 19-coronary segment model. 3 Significant coronary artery stenosis was defined by accepted standards, that is, a ≥50% diameter stenosis by QCA (equivalent to ≈70% stenosis by visual estimate).
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A detailed adjudication process between CTA and ICA was performed to ensure the correct cross-modality correspondence of segments. The patient level requires correspondence at the (nonadjudicated) vessel level. The vessel level requires correspondence at the adjudicated segment level, and only adjudicated segments seen by both modalities are included in the data rollup. If any vessel(s) is positive by QCA, only CTA in the corresponding vessel(s) is considered; if no vessels are positive by QCA, the greatest stenosis is considered for CTA regardless of vessel. The same logic applies to segments for the vessel-level analysis.
Data Acquisition and Analysis of Data From SPECT-MPI
Details on the SPECT-MPI image acquisition in the CORE320 study have been published. 10, 12 Myocardial perfusion imaging was performed using SPECT. All imaging was performed within 60 days of cardiac catheterization either clinically driven (N=160) or as part of the research protocol (N=261). Of these 421 patients, 381 also had completed CTA and QCA data. All SPECT-MPI cameras used in the study were required to undergo accreditation for quality assurance before commencement and throughout the enrollment period. Attenuation correction was not routinely used. Pharmacological stress was used in 257 patients while 124 underwent an exercise protocol. All analysis was performed in an independent core laboratory at the Brigham and Women's Hospital in Boston, MA. Two experienced readers independently interpreted SPECT images, and discrepancies were resolved by consensus. Myocardial territories were analyzed by SPECT-MPI for rest and stress myocardial perfusion abnormalities with a severity and reversibility-scored, 4-point scoring system using a 13-territory model. The summed stress score was defined as the sum of abnormal myocardial segments at stress phase. A summed stress score ≥1 defined an abnormal SPECT-MPI study in accordance with methods used for large multicenter studies and independent core laboratories. 13 Summed rest score was calculated using the same method using rest images. To assess reversible ischemia, summed difference score for each coronary artery was determined by subtracting summed rest score from summed stress score of that artery. Summed difference score ≥1 was categorized as reversible ischemia and served as the outcome variable for this analysis.
To assure coregistration of the arterial anatomy with their associated myocardial perfusion territories, an extensive adjudication process was performed. The details of this process have been published in detail. 9 In brief, an adjudication selection algorithm was created to detect studies with potentially misaligned coronary arterial anatomy with their myocardial perfusion territories. After data entry into the database, the algorithm identified potential misalignment, which then was resolved by an adjudication process involving members of the respective core laboratories. 
Statistical Analysis
All data were analyzed in the statistical core laboratory at the Bloomberg School of Public Health using SAS software, version 9.4, Stata software, version 13, and S-PLUS software, version 8.0. The primary analysis estimated the diagnostic performance of 320-row CTA imaging in the diagnosis of a stenosis of at least 50% by QCA on a per-patient, per-vessel, and per-segment basis. Computation of confidence limits for vessel-and segment-level data took account of within-patient clustering, through either logistic regression with generalized estimating equations or bootstrap resampling for area under the receiver operating characteristic curve (AUC) values. In the latter case, CIs were calculated according to the percentile method, with a β-value of 2000 replicate samples. For comparison of AUCs for CTA and ICA with the reference standard of SPECT-MPI, the method of DeLong et al 14 was used at the patient level, while bootstrapping as described above was used at the vessel level. History of unstable angina, n (%) 27 (7) 13 (5) 14 (12) Creatinine, mg/dL P of <0.05 was considered to indicate statistical significance. All P values are 2 sided, and the 95% CIs are also presented.
RESULTS
A total of 381 patients with complete imaging were enrolled in the CORE320 multicenter international clinical study between November 2009 and July 2011. Demographic and clinical characteristics of the patients are shown in Table 1 . The median age was 62 years (interquartile range, 56-68), and 66% were men. Most patients had a history of hypertension or hypercholesterolemia, and half of patients were past or current cigarette smokers (Table 1 (Table 2) .
Patient-Based Analysis
The AUC for CTA was 0.90 (95% CI, 0.87-0.93) for the diagnosis of a patient with at least 1 coronary stenosis of ≥50% as assessed by QCA ( Figure 1A ). The sensitivity for obstructive stenosis of ≥50% was 92% (95% CI, 88-95), and the specificity was 74% (95% CI, 67-81; Table 2 ). The positive and negative predictive values were 84% (95% CI, 79-89) and 86% (95% CI, 79-92), respectively, for a disease prevalence of 60%. For visual CTA, the AUC was 0.89 (95% CI, 86-92; Table 2 ). When correspondence (in at least 1 vessel) between CTA and ICA was considered, the AUC for quantitative CTA slightly changed to 0.88 (95% CI, 0.84-0.91; Table 3; Figure 1B ). The AUC was the highest in patients with zero calcium score (0.91; 95% CI, 0.81-0.96) and lowest in patients with calcium score ≥400 (0.75; 95% CI, 0.66-0.82; Table 4 ; Figure 2 ). However, sensitivity and negative predictive values were 100% in patients with calcium score ≥400 ( 
Vessel-Based Analysis
In a vessel-based analysis, the AUC for CTA was 0.87 (95% CI, 0.84-0.90) for detecting a vessel with ≥1 coronary stenosis of ≥50% as assessed by QCA (Figure 1A) . The sensitivity for obstructive stenosis of ≥50% was 83% (95% CI, 79-87), and the specificity was 78% (95% CI, 74-82; Table 2 ). The positive and negative predictive values were 71% (95% CI, 67-76) and 87% (95% CI, 84-90), respectively, for a disease prevalence of 40% (Table 2) . For visual CTA, the AUC was 0.86 (95% CI, 83-88; Table 2 ). Moreover, when correspondence (in at least 1 segment) between CTA and ICA was considered, the AUC for quantitative CTA dropped to 0.83 (95% CI, 0.80-0.86; Table 3 ; Figure 1B ). In vessel-based analyses, the AUC was the highest in patients with zero Agatston calcium score (0.95; 95% CI, 0.83-1.00) compared with those with calcium score of ≥400 (0.88; 95% CI, 0.79-0.98; Figure 2B) . As the Agatston calcium score increases, the specificity, positive, and negative predictive values all decrease ( Table 4 ). Seven of the 89 patients revascularized did not have data available on which vessel(s) were revascularized. For these patients, we assumed that revascularization was performed on any vessel with a ≥50% stenosis by ICA. Under this assumption, the AUCs for predicting vessel-specific revascularization by CTA and ICA were 0.82 (95% CI, 0.79-0.85) and 0.86 (0.83-0.88), respectively (P=0.008). Although there is a small bias introduced by using ICA to fill in missing data and then using it as a predictor, the results and comparison were not appreciably different when the 7 patients with uncertain revascularization locations were excluded.
Segment-Based Analysis
In a segment-based analysis, the AUC for CTA was 0.81 (95% CI, 0.78-0.83) for the diagnosis of a segment with at least 1 coronary stenosis of ≥50% as assessed by QCA ( Figure 1A ). The sensitivity for ob- The patient level requires correspondence at the (nonadjudicated) vessel level. The vessel level requires correspondence at the adjudicated segment level, and only adjudicated segments seen by both modalities are included in the data rollup. If any vessel(s) is positive by QCA, only CTA in the corresponding vessel(s) is considered; if no vessels are positive by QCA, the greatest stenosis is considered for CTA regardless of the vessel. The same logic applies to segments for the vessellevel analysis. AUC indicates area under the receiver operating characteristic curve; CTA, computed tomographic angiography; NPV, negative predictive value; PPV, positive predictive value; and QCA, quantitative coronary angiography. structive stenosis of ≥50% was 58% (95% CI, 54-62), and the specificity was 91% (95% CI, 90-92; Table 2 ). The positive and negative predictive values were 51% (95% CI, 46-55) and 93% (95% CI, 92-94), respectively, for a disease prevalence of 14% (Table 2). For visual CTA, the AUC was 0.80 (95% CI, 0.78-0.82; Table 2 ). In segment-based analyses, the AUC was the highest in patients with zero Agatston calcium score (0.88; 95% CI, 0.79-0.98) compared with those with calcium score of 1 to 99 (AUC, 0.76; 95% CI, 0.64-0.86; Figure 2C ). Sensitivity and negative predictive value decrease as the Agatston calcium score increases (Table 4) . 
Diagnostic Accuracy of CTA and ICA Versus SPECT-MPI

DISCUSSION
The salient findings of the present study are as follows: in patients with suspected CAD, 320-row coronary CTA yields high accuracy (AUC of 0.87-0.90) compared with ICA for identifying patients with obstructive CAD-although not better than the results reported for 64-slice CT. Furthermore, agreement between CTA and ICA on a per-vessel-and per-segment-based analyses remains modest despite advanced CT technology. As previously shown with 64-slice CT, severe coronary calcification reduces CTA specificity to identify stenoses by QCA, with overall diagnostic concordance declining despite increased sensitivity. 15 On the contrary, agreement of CTA and ICA was similar when compared with the independent outcome variable of SPECT-MPI and for identifying patients who subsequently underwent clinically driven coronary artery revascularization.
The interpretation of diagnostic accuracy studies is challenging because numerous factors affect these statistics. Lack of clinical context, observer bias, population characteristics, mode of image interpretation, and disease definition (thresholds) may introduce obstacles in addition to standard methodology issues for applying research to clinical practice. Our results reveal a wide range of diagnostic accuracy by CTA versus ICA depending on the level of analysis, that is, patient versus segment, visual versus quantitative, and according the level of coronary calcification. Much of this variability can be explained by disease prevalence. Going from patient-to segment-level analysis, disease prevalence (obstructive CAD by QCA) substantially decreases in our study from 60.1% to 13.9% and from 89.2% to 14.1% for a calcium score of ≥400 versus zero. By definition, predictive values are dependent on the disease prevalence (=de-nominator), which means the negative predictive value increases with decreasing disease prevalence, whereas the positive predictive value increases with increasing disease prevalence and vice versa. 15 Although sensitivity and specificity are not dependent on disease prevalence by definition, they tend to follow similar patterns with sensitivity being higher and specificity lower in populations with high disease prevalence with the reverse true with low disease populations. 15 It is important to note, therefore, that in a given arterial segment, CTA's negative predictive value for obstructive CAD is high, whereas its positive predictive value is rather low. On the contrary, sensitivity is high, whereas specificity is typically low in the setting of severe coronary calcification and high disease prevalence. 15 In contrast to CorE-64, specificity of CT versus ICA was lower in CORE320, demonstrating the effect of observer bias as the population characteristics were almost identical in both cohorts. While there was a conscious effort in CorE-64 to avoid overcalling stenoses (increasing specificity), the emphasis was to minimize false-negative results in CORE320, leading to higher sensitivity. 15 AUC analysis integrates test performance over a wide range of thresholds and thus reduces the effect of observer bias (values were similar for both trials). Therefore, AUC analysis is the preferred metric for expressing diagnostic accuracy rather than selecting individual point statistics (sensitivity and specificity).
Because ICA is the accepted standard for identifying patients with obstructive CAD in clinical practice, it is tempting to discredit the performance of CT in cases of disagreement for stenosis quantification. Both spatial and temporal resolutions by CT are inferior to ICA, which likely impacts accurate depiction of luminal borders. 5 Furthermore, our present study reveals that lumen assessment by CT remains challenging in the presence of severe coronary calcification using 320-detector technology, as previously demonstrated with 64-slice systems. 15 This should not surprise as the spatial resolution of the 320-slice scanner is similar to that of its 64-detector predecessor. The main advantage of volume scanning lies in faster image acquisition and fa- 5 Comparison studies of ICA with intravascular ultrasound, which is widely recognized as a more accurate tool to delineate coronary arterial anatomy, revealed only modest agreement for stenosis quantification. 16, 17 Indeed, agreement between CT and intravascular ultrasound for coronary stenosis assessment was at least equal to that between intravascular ultrasound and ICA in studies using all 3 modalities for this purpose. 18 Using complex coronary artery phantoms with simulated motions, our group found that ICA has difficulties displaying noncircular lumen geometry accurately where CT holds an advantage because of its 3-dimensional viewing technique. 19 A study using fractional flow reserve in the left main coronary artery found ICA to frequently underestimate lumen stenosis. 20 Therefore, limitations of both ICA and CTA introduce considerable uncertainty in regard to the true luminal dimensions in case of disagreement among these modalities.
Another important source of discrepant stenosis evaluation by CT and ICA is reader variability. A number of studies documented substantial differences in stenosis grading among observers of ICA. 21, 22 Leape et al 23 compared the original site readings of 308 angiograms to expert consensus evaluation. Of 29 cases with site readings of high-risk coronary anatomy (left main, 3-vessel disease, or 2-vessel disease, including the proximal LAD), only 9 original diagnoses were confirmed by the panel. More than a third of referrals for coronary artery bypass grafting deemed necessary by the performing cardiologists were classified as inappropriate or uncertain by the expert panel. Thus, it is evident that ICA as a gold standard for comparison bears considerable uncertainty in regard to its interpretation. At the same time, reader agreement is not perfect for CTA either, 24 further contributing to variability of stenosis grading between both modalities.
An imaging modality should inform medical decision-making and management. Little information is available on the comparative effectiveness of CT and ICA in this regard. In a post hoc analysis of CorE-64, both techniques perform modestly for identifying patients with provocable myocardial ischemia. 25 A recent study compared the diagnostic accuracy of ICA and CT for determining the hemodynamic significance of coronary stenoses as assessed by fractional flow reserve. 26 Diagnostic accuracy (expressed as AUC) was similar for CTA (0.75-0.77) and QCA (0.77). Our data extend these findings to provocable myocardial ischemia by myocardial perfusion imaging as outcome variable using rigorous methodology. Importantly, CTA was similarly accurate compared with ICA for identifying patients who subsequently underwent clinically driven coronary artery revascularization.
Nevertheless, ICA holds a major advantage over CT concerning data that inform management decisions. Numerous clinical trials utilized information by ICA, for example, location of stenoses and number of involved vessels, for guiding treatment of patients with CAD. Despite its attractiveness as a fast, inexpensive, noninvasive imaging tool, which typically requires less radiation and contrast doses than ICA, CT will not replace ICA unless it can show comparable performance for guiding patient management. 27 Clinical trials to test this hypothesis are underway but will take several years before results become available. In the meantime, CT serves as a gatekeeper for ICA because of its high negative predictive value in adequately selected populations. The recently completed CONSERVE trial (Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization) found almost 80% lower ICA rates in patients with suspected CAD undergoing CT. 28 Importantly, revascularization procedures and costs were lower with CTguided referral to ICA, despite equal patient outcome.
Limitations
Although all patients were prospectively enrolled, the CORE320 study was not specifically designed and powered to compare CTA with ICA. However, the narrow width of CIs supports the robustness of our results. The CORE320 is a cohort of patients with intermediatehigh risk characteristics as all patients were referred for cardiac catheterization with suspected obstructive CAD. Our results may not be applicable to lower risk populations, where CTA is typically being used in current clinical practice. Specifically, predictive values, sensitivity, and specificity often vary by disease prevalence, whereas AUC values remain less affected.
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Conclusions
CT coronary angiography utilizing 320-slice acquisition yields high accuracy in identifying patients with obstructive CAD by ICA at lower radiation exposure to patients. However, agreement between the modalities is lower when considering vessel-and segment-level analyses. Both CTA and ICA perform similarly for predicting clinically driven revascularization and for detecting myocardial ischemia by SPECT-MPI, suggesting that limitations by both CTA and ICA contribute to variability of stenosis quantification.
ARTICLE INFORMATION
Received July 6, 2018; accepted November 21, 2018.
